Design Approach based Formulation of Deformable Liposomes and their In vitro Skin Permeation

Authors

  • Rakesh Raj J.K. College of Pharmacy Bilaspur CG 495550
  • Pooja Mongia Raj Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya Bilaspur CG 495009
  • Alpana Ram Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya Bilaspur CG 495009

DOI:

https://doi.org/10.37591/tdd.v4i3.71

Abstract

Leukemia is the common cause of disease and its worldwide incidence is increasing. Cytarabine pyrimidine nucleoside analogs most widely used for the treatment of leukemia, but the major obstacles to existing treatments are adverse effect and poor patient’s compliances. To provide sustained drug release with minimum side effects and to develop more patients affable formulation, the authors investigated the transdermal delivery of cytarabine through deformable liposomes. The present work demonstrated the design of nanodeformable liposomes bearing cytarabine by design approach to minimize the experimentation. Three levels and three factors full factorial designs were used to get optimized formulation with minimum particle size and maximum entrapment. Optimized nano lipid based formulations of cytarabine were subjected to particle size, morphology and entrapment efficiency assessment. Invitro skin permeation and cell line inhibitory effect of this novel formulation were also determined. It could be confirmed that the developed transdermal formulation nanodeformable liposomes increase the transdermal flux of cytarabine as compared to drug solution or rigid liposomes and could provide a new alternative therapy for leukemia.

 

Keywords: Transfersomes, cytarabine, deformable liposomes, leukemia, skin permeation

 

Cite this Article

Rakesh Raj, Pooja Mongia Raj, Alpana Ram. Design Approach based Formulation of Deformable Liposomes and their In vitro Skin Permeation. Trends in Drug Delivery. 2017; 4(3): 14–25p.

Downloads

Published

2018-04-02

Issue

Vol. 4 No. 3 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.